title: ERK signaling leads to mitochondrial dysfunction in extracellular zinc-induced neurotoxicity.
abstract: A zinc-induced signaling pathway leading to extracellular signal-regulated kinase 1/2 (ERK1/2) activation and subsequent neuronal death has been investigated. We find that an extracellular zinc application stimulates biphasic phosphorylation of ERK1/2 and p38 MAPK in rat cultured neurons. The activation of ERK1/2, but not p38, is responsible for zinc neurotoxicity as only U0126, a MEK inhibitor that blocks ERK1/2 phosphorylation, significantly protects cortical neurons from zinc exposure. Over-expression of a dominant negative Ras mutant blocks zinc-induced Elk1-dependent gene expression in neurons, indicating the involvement of Ras activation in the zinc pathway leading to ERK phosphorylation and Elk1 signaling. We also find that zinc treatment results in neuronal mitochondrial hyperpolarization. Importantly, both U0126 and bongkrekic acid, an inhibitor of the mitochondrial adenine nucleotide translocase, effectively reduce zinc-triggered mitochondrial changes. As bongkrekic acid also prevents zinc-triggered neuronal death but not ERK1/2 phosphorylation, activation of MAPK signaling precedes and is required for mitochondrial dysfunction and cell death. These results provide new insight on the mechanism of extracellular zinc-induced toxicity in which the regulation of mitochondrial function by the Ras/MEK/ERK pathway is closely associated with neuronal viability.
authors.affiliation: Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
authors.forename: Kai
authors.initials: K
authors.lastname: He
authors.forename: Elias
authors.initials: E
authors.lastname: Aizenman
mesh_terms: D000818:Animals; D016923:Cell Death; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002712:Chlorides / Q000633:toxicity; D004789:Enzyme Activation; D005110:Extracellular Space / Q000378:metabolism*; D020935:MAP Kinase Signaling System; D053078:Membrane Potential, Mitochondrial; D008928:Mitochondria / Q000187:drug effects / Q000502:physiology*; D019950:Mitogen-Activated Protein Kinase 1 / Q000502:physiology*; D048052:Mitogen-Activated Protein Kinase 3 / Q000502:physiology*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley; D015032:Zinc / Q000502:physiology*; D017967:Zinc Compounds / Q000633:toxicity; D050807:ets-Domain Protein Elk-1 / Q000502:physiology; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism; D018631:ras Proteins / Q000502:physiology
chemical_list: D002712:Chlorides; C494114:Elk1 protein, rat; D017967:Zinc Compounds; D050807:ets-Domain Protein Elk-1; C016837:zinc chloride; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D048051:p38 Mitogen-Activated Protein Kinases; D018631:ras Proteins; D015032:Zinc
references.citation: J Neurochem. 1997 May;68(5):1836-45
references.pmid: 9109508
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5155-60
references.pmid: 16549787
references.citation: J Biol Chem. 2006 Nov 24;281(47):36228-35
references.pmid: 17015444
references.citation: Trends Immunol. 2004 Jul;25(7):360-7
references.pmid: 15207503
references.citation: J Neurosci. 1998 Jan 1;18(1):214-26
references.pmid: 9412502
references.citation: J Biol Chem. 2001 Dec 14;276(50):47524-9
references.pmid: 11595748
references.citation: Nat Rev Neurosci. 2009 Jul;10(7):481-94
references.pmid: 19543220
references.citation: J Neurosci. 2001 Jul 15;21(14):5054-65
references.pmid: 11438581
references.citation: Apoptosis. 2006 Nov;11(11):1933-44
references.pmid: 17013754
references.citation: J Neurochem. 2001 Aug;78(3):600-10
references.pmid: 11483663
references.citation: Mol Pharmacol. 2008 Oct;74(4):1141-51
references.pmid: 18635668
references.citation: J Neurosci. 2000 Jun 1;20(11):RC79
references.pmid: 10807937
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2414-9
references.pmid: 10051656
references.citation: Exp Neurol. 2009 Aug;218(2):203-12
references.pmid: 19341732
references.citation: J Biol Chem. 1995 Sep 8;270(36):21195-8
references.pmid: 7673152
references.citation: J Biol Chem. 2006 Jun 16;281(24):16436-42
references.pmid: 16621802
references.citation: J Neurosci. 2004 Nov 24;24(47):10616-27
references.pmid: 15564577
references.citation: J Biol Chem. 2002 Nov 8;277(45):43377-88
references.pmid: 12218054
references.citation: J Biol Chem. 1998 Jul 17;273(29):18623-32
references.pmid: 9660836
references.citation: J Neurosci. 1998 Jun 1;18(11):4042-9
references.pmid: 9592085
references.citation: J Biol Chem. 2000 Aug 4;275(31):23911-8
references.pmid: 10801816
references.citation: Mitochondrion. 2005 Feb;5(1):55-65
references.pmid: 16060292
references.citation: Eur J Neurosci. 1999 Jan;11(1):327-34
references.pmid: 9987035
references.citation: Eur J Neurosci. 2000 Oct;12(10):3813-8
references.pmid: 11029652
references.citation: J Neurosci. 2009 Jul 15;29(28):9002-10
references.pmid: 19605638
references.citation: J Neurosci. 2001 Jul 1;21(13):4551-63
references.pmid: 11426445
references.citation: Trends Pharmacol Sci. 2000 Oct;21(10):395-401
references.pmid: 11050320
references.citation: ACS Chem Biol. 2006 Mar 17;1(2):103-11
references.pmid: 17163650
references.citation: Sci STKE. 2004 Sep 14;2004(251):PE45
references.pmid: 15383672
references.citation: Curr Med Chem. 2003 Aug;10(16):1507-25
references.pmid: 12871123
references.citation: J Neurochem. 1999 Aug;73(2):450-6
references.pmid: 10428039
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11569-74
references.pmid: 11504919
references.citation: Nat Neurosci. 2009 Jun;12(6):725-7
references.pmid: 19430470
references.citation: Nat Methods. 2006 Jun;3(6):455-60
references.pmid: 16721379
references.citation: EMBO J. 1994 Dec 15;13(24):5922-8
references.pmid: 7813431
references.citation: Apoptosis. 2006 Apr;11(4):473-85
references.pmid: 16532373
references.citation: J Neurosci. 2006 Jun 21;26(25):6851-62
references.pmid: 16793892
references.citation: Mol Cell. 2006 Feb 17;21(4):481-93
references.pmid: 16483930
references.citation: Diabetes. 2010 Apr;59(4):967-77
references.pmid: 20071600
references.citation: J Neurosci. 2002 Sep 1;22(17):7408-16
references.pmid: 12196562
references.citation: J Neurosci. 2009 Mar 4;29(9):2890-901
references.pmid: 19261885
references.citation: J Neurosci. 2001 May 15;21(10):3303-11
references.pmid: 11331359
references.citation: J Neurochem. 2004 Apr;89(1):248-56
references.pmid: 15030409
references.citation: J Neurosci. 2000 Dec 1;20(23):RC111
references.pmid: 11090611
references.citation: J Biol Chem. 2005 Feb 18;280(7):5875-83
references.pmid: 15579467
references.citation: Am J Physiol Cell Physiol. 2002 Jul;283(1):C273-81
references.pmid: 12055096
references.citation: J Neurochem. 2000 Nov;75(5):1878-88
references.pmid: 11032877
references.citation: Nature. 2007 Jun 14;447(7146):864-8
references.pmid: 17568748
references.citation: J Clin Invest. 2005 Jul;115(7):1828-38
references.pmid: 15937550
references.citation: Nat Rev Neurosci. 2009 Nov;10(11):780-91
references.pmid: 19826435